About Strepsils
Strepsils is one of the world's most trusted sore throat brands, with origins dating back to 1950 when the Boots Company developed it as an antiseptic mouthwash. In 1958, the formula was innovatively reformulated into the throat lozenges that would become a British medicine cabinet staple for generations. The brand name cleverly references Streptococcus, the bacterium responsible for certain types of sore throat, immediately communicating the product's targeted purpose to consumers. For nearly 50 years, Strepsils was part of the Boots pharmaceutical portfolio. In October 2005, Reckitt Benckiser acquired Boots Healthcare International for £1.9 billion, bringing three major brands into their fold: Nurofen analgesics, Strepsils sore throat lozenges, and Clearasil anti-acne treatments. Following Reckitt Benckiser's 2021 rebrand to simply Reckitt, Strepsils continues as a core component of their consumer health offerings alongside established brands like Gaviscon, Mucinex, and Durex, trusted in over 50 countries worldwide. The Strepsils range has expanded significantly from its original formulation to address diverse consumer needs. The classic antiseptic lozenges remain popular, containing dichlorobenzyl alcohol and amylmetacresol to target throat bacteria. Flavour options include the beloved Honey & Lemon, refreshing Orange with added Vitamin C, Strawberry, Blackcurrant, and the original flavour. Sugar-free versions cater to those monitoring sugar intake whilst still providing effective relief. For more intense symptoms, Strepsils Extra offers Triple Action formula with added anaesthetic for stronger pain relief, available in Cherry and Blackcurrant flavours. The Strepsils Sore Throat & Cough variant addresses multiple symptoms simultaneously. Available throughout UK supermarkets including Ocado, Tesco, Asda, and Iceland, Strepsils remains the go-to choice for millions of British households when sore throat strikes, continuing over six decades of heritage in throat care.